|
"shih jy"的相關文件
顯示項目 1-10 / 32 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-01 |
Atezolizumab, bevacizumab, pemetrexed and platinum for EGFR-mutant NSCLC patients after EGFR TKI failure: A phase II study with immune cell profile analysis
|
Wu, SG;Ho, CC;Yang, JC;Yu, SH;Lin, YF;Lin, SC;Liao, BC;Yang, CY;Lin, YT;Yu, CJ;Chuang, YT;Liao, WY;Yap, KY;Kou, WS;Shih, JY |
| 國家衛生研究院 |
2023-11-29 |
Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: A prospective cohort study
|
Chang, GC;Chiu, CH;Yu, CJ;Chang, YC;Chang, YH;Hsu, KH;Wu, YC;Chen, CY;Hsu, HH;Wu, MT;Yang, CT;Chong, IW;Lin, YC;Hsia, TC;Lin, MC;Su, WC;Lin, CB;Lee, KY;Wei, YF;Lan, GY;Chan, WP;Wang, KL;Wu, MH;Tsai, HH;Chian, CF;Lai, RS;Shih, JY;Wang, CL;Hsu, JS;Chen, KC;Chen, CK;Hsia, JY;Peng, CK;Tang, EK;Hsu, CL;Chou, TY;Shen, WC;Tsai, YH;Tsai, CM;Chen, YM;Lee, YC;Chen, HY;Yu, SL;Chen, CJ;Wan, YL;Hsiung, CA;Yang, PC |
| 臺大學術典藏 |
2022-09-08T07:32:27Z |
The Long-Term and Mediating Effects of Mindfulness Integrated with Body-Mind-Spirit Group Therapy on Depressive Symptoms and Quality of Life Among Non-small Cell Lung Cancer Patients
|
Hsiao, FH; Lin, ZZ; Huang, FY; Lai, YM; Chen, YT; Shih, JY; CHAO-CHI HO; Yu, CJ; Hsieh, CC |
| 中山醫學大學 |
2021 |
Subsequent Antituberculous Treatment May Not Be Mandatory Among Surgically Resected Culture-Negative Pulmonary Granulomas: A Retrospective Nationwide Multicenter Cohort Study
|
Chung, CL; Huang, WC; Huang, HL; Chin, CS; Cheng, MH; Lee, MR; Lin, SH; Wang, JY; Lin, CH; Chong, IW; Shih, JY; Yu, CJ |
| 中山醫學大學 |
2021 |
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
|
Chang, GC; Lam, DCL; Tsai, CM; Chen, YM; Shih, JY; Aggarwal, S; Wang, SH; Kim, SW; Kim, YC; Wahid, I; Li, RB; Lim, DWT; Sriuranpong, V; Chan, RTT; Lorence, RM; Carriere, P; Raabe, C; Cseh, A; Park, K |
| 中山醫學大學 |
2020 |
An Observational Study of AcquiredEGFRT790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan
|
Wu, SG; Chiang, CL; Liu, CY; Wang, CC; Su, PL; Hsia, TC; Shih, JY; Chang, GC |
| 中國醫藥大學 |
2015-05 |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations
|
(Chiu CH)*;(Yang CT);(Shih JY);(Huang MS);(Su WC);(Lai RS);(Wang CC);(Hsiao SH);(Lin YC);(Ho CL);夏德椿(Te-Chun Hsia);(Wu MF) |
| 亞洲大學 |
2011-04 |
Slug Confers Resistance to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
|
余永倫;Yu, Yung-luen;Yang CH, ;Lin SB, ;Wu, CP;Shih, JY;Yang, PC |
| 國家衛生研究院 |
2009-03-24 |
Rapid efficacy assessment method for lung cancer therapy
|
nan, PK;Sher, YP;Shih, JY;Yang, PC;Wu, CW |
| 大葉大學 |
2008-12-5 |
Good Response to Gefitinib in Lung Adenocarcinoma of Complex Epidermal Growth Factor Receptor (EGFR) Mutations with the Classical Mutation Pattern.
|
Wu, SG;Chang, YL;Hsu, YC;Wu, JY;Yang, CH;Yu, CJ;Tsai, Meng-Feng;Shih, JY;Yang, PC |
顯示項目 1-10 / 32 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
